1 recruiting, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Venous Thromboembolic Disease: new trials by email Literature Review of Venous Thromboembolic Disease trials Research Report on Venous Thromboembolic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets Full-dose anticoagulant therapy (AC), Antiplatelet therapy (AP) - Venous Thromboembolic Disease | Phase 3 | Recruiting | Centre Hospitalier Universitaire de Saint Etienne | 1400 | 2023-08-16 | 2026-05-08 |
| Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation ATI-5923, Coumadin (warfarin) - Atrial Fibrillation, Atrial Flutter | Phase 2 / Phase 3 | Unknown | ARYx Therapeutics | 600 | 2008-05-01 | 2010-02-02 |
Atrial Fibrillation (1) · Atrial Flutter (1) · Cardiomyopathies (1) · Myocardial Infarction (1) · Pulmonary Embolism (1) · Venous Thromboembolism (1) · Venous Thrombosis (1)
Cardiovascular Diseases (2) · Vascular Diseases (2) · Arrhythmias, Cardiac (1) · Embolism (1) · Embolism and Thrombosis (1) · Heart Diseases (1) · Infarction (1) · Ischemia (1) · Lung Diseases (1) · Myocardial Ischemia (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Thromboembolism (1)
Warfarin (1) · tecarfarin (1)
ARYx Therapeutics (1) · Centre Hospitalier Universitaire de Saint Etienne (1)
France (1) · United States (1)